Sandgren, EP, Schroeder, JA, Qui, TH, Palmiter, RD, Brinster, RL and Lee, DC. (1995). Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 55: 3915-3927.
Berkowitz, EA, Seroogy, KB, Schroeder, JA, Russell, WE, Evans, EP, Riedel, RF, Phillips, HK, Harrison, CA, Lee, DC and Luetteke, NC. (1996). Characterization of the mouse transforming growth factor alpha gene: its expression during eyelid development and in waved 1 tissues. Cell Growth Differ. 7: 1271-1282
Clark, GJ, Drugan, JK, Rossman, KL, Carpenter, JW, Rogers-Graham, K, Fu, H, Der, CJ and Campbell, SL. (1997). 14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J Biol Chem. 272: 20990-20993.
Schroeder, JA and Lee, DC. (1997). Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia. 2: 119-129.
Whitehead, IP, Campbell, S, Rossman, KL and Der, CJ. (1997). Dbl family proteins. Biochem Biophys Acta. 1332: F1-23.
Schroeder, JA. and Lee, DC. (1998). Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 9: 451-464.
Khosravi-Far, R, Campbell, S, Rossman, KL and Der, CJ. (1998). Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res. 72: 57-107.
Zohn, IM, Campbell, SL, Khosravi-Far, R, Rossman, KL. and Der, C. J. (1998). Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene. 17: 1415-1438.
Campbell, S. L, Khosravi-Far, R, Rossman, K.L, Clark, G. J. and Der, C. J. (1998). Increasing complexity of Ras signaling. Oncogene. 17: 1395-1413.
Whitehead, I. P, Lambert, Q. T, Glaven, J. A, Abe, K, Rossman, KL, Mahon, GM, Trzaskos, JM, Kay, R, Campbell, SL and Der, CJ. (1999). Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol. 19: 7759-7770.
DeCristofaro, MF, Betz, BL, Wang, W and Weissman, BE. (1999). Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms’ tumors. Oncogene. 18: 7559-7565.
Thomas, JW, Cooley, MA, Broome, JM, Salgia, R, Griffin, JD, Lombardo, CR and Schaller, MD. (1999). The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin. J Biol Chem. 274: 36684-36692.
Cooley, MA, Broome, JM, Ohngemach, C, Romer, LH and Schaller, MD. (2000). Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase. Mol Biol Cell. 11: 3247-3263.
Rusyn, EV, Reynolds, ER, Shao, H, Grana, TM, Chan, TO, Andres, DA and Cox, AD. (2000). Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Oncogene. 19: 4685-4694.
Williams, JG, Drugan, JK, Yi, GS, Clark, GJ, Der, CJ and Campbell, SL. (2000). Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions. J Biol Chem. 275: 22172-22179.
Abe, K, Rossman, KL, Liu, B, Ritola, KD, Chiang, D, Campbell, SL, Burridge, K and Der, CJ. (2000). Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem. 275: 10141-10149.
Schroeder, JA, Troyer, KL and Lee, DC. (2000). Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Oncogene. 19: 3193-3199.